Expression and function of immunoglobulin-like transcripts on tolerogenic dendritic cells

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The expression of inhibitory immunoglobulin-like transcripts (ILTs) on dendritic cells (DCs) is a biomarker of tolerogenic DCs. In this article we discuss current knowledge on the function of ILTs and explore the molecular mechanisms involved in modulation of DCs via the inhibitory receptor and its natural ligand, rendering these cells tolerogenic. We propose a method to enhance targeting of inhibitory receptors on DCs using microparticles containing a preferential ligand, HLA-G, and monoclonal antibody against the pan-DCs marker CD11c. The double-coated microparticles increase the binding of ILT4 receptor and improve modulation of DCs in vitro and in vivo. This targeting concept can be used for regulation of specific immune responses to antigens in transplantation, autoimmunity, allergy, and cancer.

Original languageEnglish (US)
Pages (from-to)353-356
Number of pages4
JournalHuman Immunology
Volume70
Issue number5
DOIs
StatePublished - May 1 2009

Fingerprint

Dendritic Cells
Immunoglobulins
HLA-G Antigens
Ligands
Histocompatibility Antigens Class II
Autoimmunity
Hypersensitivity
Transplantation
Biomarkers
Monoclonal Antibodies
Neoplasms

Keywords

  • Dendritic cells
  • Immunotherapy
  • Inhibitory receptors
  • Tolerance
  • Transplantation

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Expression and function of immunoglobulin-like transcripts on tolerogenic dendritic cells. / Wu, Juan; Horuzsko, Anatolij.

In: Human Immunology, Vol. 70, No. 5, 01.05.2009, p. 353-356.

Research output: Contribution to journalArticle

@article{83fe027a61464526aeee6debf0355312,
title = "Expression and function of immunoglobulin-like transcripts on tolerogenic dendritic cells",
abstract = "The expression of inhibitory immunoglobulin-like transcripts (ILTs) on dendritic cells (DCs) is a biomarker of tolerogenic DCs. In this article we discuss current knowledge on the function of ILTs and explore the molecular mechanisms involved in modulation of DCs via the inhibitory receptor and its natural ligand, rendering these cells tolerogenic. We propose a method to enhance targeting of inhibitory receptors on DCs using microparticles containing a preferential ligand, HLA-G, and monoclonal antibody against the pan-DCs marker CD11c. The double-coated microparticles increase the binding of ILT4 receptor and improve modulation of DCs in vitro and in vivo. This targeting concept can be used for regulation of specific immune responses to antigens in transplantation, autoimmunity, allergy, and cancer.",
keywords = "Dendritic cells, Immunotherapy, Inhibitory receptors, Tolerance, Transplantation",
author = "Juan Wu and Anatolij Horuzsko",
year = "2009",
month = "5",
day = "1",
doi = "10.1016/j.humimm.2009.01.024",
language = "English (US)",
volume = "70",
pages = "353--356",
journal = "Human Immunology",
issn = "0198-8859",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Expression and function of immunoglobulin-like transcripts on tolerogenic dendritic cells

AU - Wu, Juan

AU - Horuzsko, Anatolij

PY - 2009/5/1

Y1 - 2009/5/1

N2 - The expression of inhibitory immunoglobulin-like transcripts (ILTs) on dendritic cells (DCs) is a biomarker of tolerogenic DCs. In this article we discuss current knowledge on the function of ILTs and explore the molecular mechanisms involved in modulation of DCs via the inhibitory receptor and its natural ligand, rendering these cells tolerogenic. We propose a method to enhance targeting of inhibitory receptors on DCs using microparticles containing a preferential ligand, HLA-G, and monoclonal antibody against the pan-DCs marker CD11c. The double-coated microparticles increase the binding of ILT4 receptor and improve modulation of DCs in vitro and in vivo. This targeting concept can be used for regulation of specific immune responses to antigens in transplantation, autoimmunity, allergy, and cancer.

AB - The expression of inhibitory immunoglobulin-like transcripts (ILTs) on dendritic cells (DCs) is a biomarker of tolerogenic DCs. In this article we discuss current knowledge on the function of ILTs and explore the molecular mechanisms involved in modulation of DCs via the inhibitory receptor and its natural ligand, rendering these cells tolerogenic. We propose a method to enhance targeting of inhibitory receptors on DCs using microparticles containing a preferential ligand, HLA-G, and monoclonal antibody against the pan-DCs marker CD11c. The double-coated microparticles increase the binding of ILT4 receptor and improve modulation of DCs in vitro and in vivo. This targeting concept can be used for regulation of specific immune responses to antigens in transplantation, autoimmunity, allergy, and cancer.

KW - Dendritic cells

KW - Immunotherapy

KW - Inhibitory receptors

KW - Tolerance

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=65049085695&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65049085695&partnerID=8YFLogxK

U2 - 10.1016/j.humimm.2009.01.024

DO - 10.1016/j.humimm.2009.01.024

M3 - Article

VL - 70

SP - 353

EP - 356

JO - Human Immunology

JF - Human Immunology

SN - 0198-8859

IS - 5

ER -